Human studies begin on artificial Intelligence discovered COVID-19 treatment with up to 97 percent effectiveness

PR Newswire Article CALGARY, AB. and BATON ROUGE, La., Aug. 11, 2021 /PRNewswire/ — Skymount Medical, a drug discovery company, and Louisiana State University (LSU) announced today that human studies have begun on its unique combination of therapies, known as SM-19, for COVID-19 patients. In vitro (cell) and in … Read More

iCo Therapeutics Announces Joint Development of iCo-019 with Skymount Medical

NewsFileCorp Article Vancouver, British Columbia–(Newsfile Corp. – December 31, 2020) – iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”), iCo Therapeutics, Inc. (“iCo”) and Skymount Medical, Inc. (“Skymount”) announced today that they have entered into a non-binding Memorandum … Read More

Skymount Medical Partners with LSU to Test COVID-19 Treatments Discovered by AI

ISU EDU Article Artificial intelligence software developed by an interdisciplinary team of LSU researchers could shorten the time for drug development from 15 years to 15 days; save lives, reduce symptoms. BATON ROUGE, June 5, 2020 — A Calgary-based technology company, Skymount … Read More